References
1. Fokkens W, Landis B, Hopkins C, Reitsma S, Sedaghat A. Rhinology in
review: from COVID-19 to biologicals. Rhinology. 2021.
2. Babaei A, Iravani K, Malekpour B, Golkhar B, Soltaniesmaeili A,
Hosseinialhashemi M. Factors associated with anosmia recovery rate in
COVID‐19 patients. Laryngoscope Investigative Otolaryngology.2021;6(6):1248-1255.
3. Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. The
central role of the nasal microenvironment in the transmission,
modulation, and clinical progression of SARS-CoV-2 infection.Mucosal immunology. 2021;14(2):305-316.
4. Whitcroft K, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of
intranasal sodium citrate on olfaction in post‐infectious loss: results
from a prospective, placebo‐controlled trial in 49 patients.Clinical Otolaryngology. 2017;42(3):557-563.
5. Whitcroft K, Gunder N, Cuevas M, et al. Intranasal sodium citrate in
quantitative and qualitative olfactory dysfunction: results from a
prospective, controlled trial of prolonged use in 60 patients.European Archives of Oto-Rhino-Laryngology. 2021:1-7.
6. Hart JR. Ethylenediaminetetraacetic acid and related chelating
agents. Ullmann’s encyclopedia of industrial chemistry. 2000.
7. Benes DM, Burnett CL. Final report on the safety assessment of
pentasodium pentetate and pentetic acid as used in cosmetics.International journal of toxicology. 2008;27:71-92.
8. Sniffin’Sticks HT. Olfactory Performance Assessed by the Combined
Testing of Odor Identification, Odor Discrimination and Olfactory
Threshold. Chemical Senses. 1997;22(1):39-52.
9. Burke W. The ionic composition of nasal fluid and its function.Health. 2014;2014.
10. Švancara I, Vytřas K, Kalcher K, Walcarius A, Wang J. Carbon paste
electrodes in facts, numbers, and notes: a review on the occasion of the
50‐years jubilee of carbon paste in electrochemistry and
electroanalysis. Electroanalysis: An International Journal Devoted
to Fundamental and Practical Aspects of Electroanalysis.2009;21(1):7-28.
11.Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common
findings in COVID‐19 patients. The Laryngoscope.2020;130(7):1787-1787.
12. Gorzkowski V, Bevilacqua S, Charmillon A, et al. Evolution of
olfactory disorders in COVID‐19 patients. The Laryngoscope.2020;130(11):2667-2673.
13. Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory
Dysfunction in Coronavirus Disease 2019 (COVID‐19): A Meta‐analysis of
27,492 Patients. The Laryngoscope. 2021;131(4):865-878.
14. Ronnett GV, Moon C. G proteins and olfactory signal transduction.Annual review of physiology. 2002;64(1):189-222.
15. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the
“Sniffin’Sticks” including tests of odor identification, odor
discrimination, and olfactory thresholds: an upgrade based on a group of
more than 3,000 subjects. European Archives of
Oto-Rhino-Laryngology. 2007;264(3):237-243.
16. Rumeau C, Nguyen D, Jankowski R. How to assess olfactory performance
with the Sniffin’Sticks test®. European Annals of
Otorhinolaryngology, Head and Neck Diseases. 2016;133(3):203-206.
Table 1: Patient’s characteristics